Emerging Stocks Down Under 27 July 2021: Australian Clinical Labs, Xref, ImExHs

Emerging Stocks Down Under: Australian Clinical Labs, Xref, ImExHs

Australian Clinical Labs: Failing the value test

In today's edition of Emerging Stocks Down Under, headquartered in the Melbourne suburb of Clayton, Australian Clinical Labs provides clinical laboratory services using approximately 1,000 collection centres across Australia. The company offers all major tests, including immunology, drug and alcohol testing, routine and advanced pathology, and much more. Despite the demand for stocks in the testing industry, the company’s 14 May 2021 IPO was a rather spectacular flop. Even at the lower price Australian Clinical Labs still doesn’t pass our value test.   Also in today's edition, a look at resume fraud prevention platform developer Xref (ASX: XF1) and healthcare-focused cloud-based imaging product developer ImExHs (ASX: IME).  

Click here to read the previous edition of Emerging Stocks Down Under published 20 July 2021

For in-depth research reports or to keep up-to-date on the latest Stocks Down Under news see our parent company, Pitt Street Research, or follow us on Facebook and Twitter.

Please register or upgrade your plan to access this content.

Save $$$
30-Day Free Trial
$0
No Credit Card Required!
Get access to 4 publications
Weekly Investor Webinar
Access to Marc & Stuart's Top Picks
Profit Premium
$69
Get access to 4 publications
Access to the full research Archive
Weekly Investor Webinar
Access to Marc & Stuart's Top Picks
30-Day Free Trial
$0
No Credit Card Required!
Get access to 4 publications
Weekly Investor Webinar
Access to Marc & Stuart's Top Picks
Profit Premium
$59
BILLED ANNUALLY
Get access to 4 publications
Access to the full research Archive
Weekly Investor Webinar
Access to Marc & Stuart's Top Picks